Abstract
Members of the family Poxviridae cause diseases such as smallpox and monkeypox, which are pathogenic to humans and negatively affect animal husbandry and development. The deadly smallpox virus was eradicated by large-scale intensive vaccination with live Vaccinia virus (VACV). However, in recent years, other VACVs have emerged as threats to human and animal health in developing countries. Vaccination is the most effective and widely used means of prevention and control of viral diseases. Different types of vaccines have been used to control poxvirus infection, including traditional attenuated, nucleic acids, recombinant subunits, virus vectors, polypeptides, gene deletions, and inactived vaccines. This review summarizes recent advances in the field of poxvirus vaccine research. It also discusses existing gaps and forecasts potential directions for future research.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
